{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:58:06Z","timestamp":1762865886052},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T00:00:00Z","timestamp":1317600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2105-12-386","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T06:31:59Z","timestamp":1319524319000},"source":"Crossref","is-referenced-by-count":15,"title":["Cross-validated stepwise regression for identification of novel non-nucleoside reverse transcriptase inhibitor resistance associated mutations"],"prefix":"10.1186","volume":"12","author":[{"given":"Koen","family":"Van der Borght","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Van Craenenbroeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Lecocq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margriet","family":"Van Houtte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Van Kerckhove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Bacheler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"van Vlijmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,3]]},"reference":[{"key":"4867_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jviromet.2007.05.009","volume":"145","author":"H Vermeiren","year":"2007","unstructured":"Vermeiren H, Van Craenenbroeck E, Alen P, Bacheler L, Picchio G, Lecocq P: Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling. J Virol Methods 2007, 145: 47\u201355. 10.1016\/j.jviromet.2007.05.009","journal-title":"J Virol Methods"},{"issue":"46","key":"4867_CR2","doi-asserted-by":"publisher","first-page":"17355","DOI":"10.1073\/pnas.0607274103","volume":"103","author":"SY Rhee","year":"2006","unstructured":"Rhee SY, Taylor J, Wadhera G, Ben-Hur A, Brutlag DL, Shafer RW: Genotypic predictors of human immunodeficiency virus type 1 drug resistance. Proc Natl Acad Sci USA 2006, 103(46):17355\u201317360. 10.1073\/pnas.0607274103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"4867_CR3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/135965350400900307","volume":"9","author":"K Wang","year":"2004","unstructured":"Wang K, Jenwitheesuk E, Samudrala R, Mittler JE: Simple linear model provides highly accurate genotypic predictions of HIV-1 drug resistance. Antivir Ther 2004, 9(3):343\u2013352.","journal-title":"Antivir Ther"},{"key":"4867_CR4","volume-title":"Applied Linear Statistical Models","author":"MH Kutner","year":"2004","unstructured":"Kutner MH, Neter J, Nachtsheim CJ, Li W: Applied Linear Statistical Models. McGraw Hill; 2004."},{"key":"4867_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-21606-5","volume-title":"The Elements of Statistical Learning","author":"T Hastie","year":"2001","unstructured":"Hastie T: The Elements of Statistical Learning. Springer; 2001."},{"key":"4867_CR6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H: A new look at the statistical model identification. IEEE Trans Automat Contr 1974, 19: 716\u2013723. 10.1109\/TAC.1974.1100705","journal-title":"IEEE Trans Automat Contr"},{"issue":"2","key":"4867_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1214\/aos\/1176344136","volume":"6","author":"G Schwarz","year":"1978","unstructured":"Schwarz G: Estimating the dimension of a model. Ann Stat 1978, 6(2):461\u2013464. 10.1214\/aos\/1176344136","journal-title":"Ann Stat"},{"issue":"2","key":"4867_CR8","first-page":"123","volume":"24","author":"L Breiman","year":"1996","unstructured":"Breiman L: Bagging Predictors. Machine Learning 1996, 24(2):123\u2013140.","journal-title":"Machine Learning"},{"key":"4867_CR9","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","volume-title":"An Introduction to the Bootstrap","author":"B Efron","year":"1994","unstructured":"Efron B, Tibshirani R: An Introduction to the Bootstrap. Chapman and Hall\/CRC; 1994."},{"key":"4867_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1198\/0003130043277","volume":"58","author":"P Austin","year":"2004","unstructured":"Austin P, Tu J: Bootstrap Methods for Developing Predictive Models. Am Stat 2004, 58: 131\u2013137. 10.1198\/0003130043277","journal-title":"Am Stat"},{"issue":"3","key":"4867_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/biomet\/76.3.503","volume":"76","author":"P Burman","year":"1989","unstructured":"Burman P: A Comparative Study of Ordinary Cross-Validation, v-Fold Cross-Validation and the Repeated Learning-Testing Methods. Biometrika 1989, 76(3):503\u2013514.","journal-title":"Biometrika"},{"key":"4867_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/01621459.1993.10476299","volume":"88","author":"J Shao","year":"1993","unstructured":"Shao J: Linear Model Selection by Cross-Validation. J Am Stat Ass 1993, 88: 486\u2013494. 10.2307\/2290328","journal-title":"J Am Stat Ass"},{"key":"4867_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1214\/aos\/1176349027","volume":"21","author":"P Zhang","year":"1993","unstructured":"Zhang P: Model Selection Via Multifold Cross Validation. Ann Stat 1993, 21: 299\u2013313. 10.1214\/aos\/1176349027","journal-title":"Ann Stat"},{"key":"4867_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/135965350901400114","volume":"14","author":"L Tambuyzer","year":"2009","unstructured":"Tambuyzer L, Azijn H, Rimsky LT, Vingerhoets J, Lecocq P, Kraus G, Picchio G, de B\u00e9thune MP: Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors. Antivir Ther 2009, 14: 103\u2013109.","journal-title":"Antivir Ther"},{"key":"4867_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1086\/315673","volume":"182","author":"AD Sevin","year":"2000","unstructured":"Sevin AD, DeGruttola V, Nijhuis M, Schapiro JM, Foulkes AS, Para MF, Boucher CA: Methods for Investigation of the Relationship between Drug-Susceptibility Phenotype and Human Immunodeficiency Virus Type 1 Genotype with Applications to AIDS Clinical Trials Group 333. J Infect Dis 2000, 182: 59\u201367. 10.1086\/315673","journal-title":"J Infect Dis"},{"key":"4867_CR16","volume-title":"Information Retrieval","author":"C van Rijsbergen","year":"1979","unstructured":"van Rijsbergen C: Information Retrieval. Butterworths, London; 1979."},{"issue":"Suppl 3","key":"4867_CR17","first-page":"A26","volume":"13","author":"J Vingerhoets","year":"2008","unstructured":"Vingerhoets J, Peeters M, Azijn H, Tambuyzer L, Hoogstoel A, Nijs S, de B\u00e9thune MP, Picchio G: An update of the list of NNRTI mutations associated with decreased virologic response to etravirine: multivariate analyses on the pooled DUET-1 and DUET-2 clinical trial data. Antivir Ther 2008, 13(Suppl 3):A26.","journal-title":"Antivir Ther"},{"key":"4867_CR18","first-page":"S51","volume":"10","author":"Y Verlinden","year":"2005","unstructured":"Verlinden Y, Vermeiren H, Lecocq P, Bacheler L, McKenna P, Vanpachtenbeke M, Horvat LI, Van Houtte M, Stuyver LJ: Assessment of the antivirogram\u00aeperformance over time including a revised definition of biological test cut-off values. Antivir Ther 2005, 10: S51.","journal-title":"Antivir Ther"},{"key":"4867_CR19","first-page":"2","volume":"1","author":"M Van Houtte","year":"2010","unstructured":"Van Houtte M, Van Walle I, Van der Borght K, Muyldermans G, Pattery T, Bacheler L, Sista P: Rare HIV-1 drug resistance mutations exert subtle synergistic and antagonistic effects in the context of the genetic background. Rev Antivir Ther Infect Dis 2010, 1: 2.","journal-title":"Rev Antivir Ther Infect Dis"},{"key":"4867_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1073\/pnas.0609642104","volume":"104","author":"GN Nikolenko","year":"2007","unstructured":"Nikolenko GN, Delviks-Frankenberry KA, Palmer S, Maldarelli F, Fivash MJ, Coffin JM, Pathak VK: Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistance. Proc Natl Acad Sci USA 2007, 104: 317\u2013322. 10.1073\/pnas.0609642104","journal-title":"Proc Natl Acad Sci USA"},{"key":"4867_CR21","volume-title":"16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada","author":"R Paredes","year":"2009","unstructured":"Paredes R, Bannister W, Cozzi-Lepri A, Pou C, Bellido R, Bogner J, Gargalianos P, Banhegyi D, Clotet B, Lundgren JD, the EuroSIDA Study Group: Mutation A376S in the RT Connection Domain Is Associated with an Increased Risk of Virological Failure to Nevirapine-Based Therapy in NNRTI-Na\u00efve HIV-Infected Subjects in the EuroSIDA Study. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada 2009. Abstract 646 Abstract 646"},{"key":"4867_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1742-6405-7-38","volume":"7","author":"K Steegen","year":"2010","unstructured":"Steegen K, Bronze M, Van Craenenbroeck E, Winters B, Van der Borght K, Wallis CL, Stevens W, Rinke de Wit TF, Stuyver LJ, the ART-A consortium: A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences. AIDS Res Ther 2010, 7: 38.","journal-title":"AIDS Res Ther"},{"issue":"15","key":"4867_CR23","doi-asserted-by":"publisher","first-page":"F41","DOI":"10.1097\/00002030-200210180-00002","volume":"16","author":"JM Whitcomb","year":"2002","unstructured":"Whitcomb JM, Huang W, Limoli K, Paxinos E, Wrin T, Skowron G, Deeks SG, Bates M, Hellmann NS, Petropoulos CJ: Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates. AIDS 2002, 16(15):F41-F47. 10.1097\/00002030-200210180-00002","journal-title":"AIDS"},{"issue":"7","key":"4867_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.aids.0000222069.14878.44","volume":"20","author":"SA Clark","year":"2006","unstructured":"Clark SA, Shulman NS, Bosch RJ, Mellors JW: Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors. AIDS 2006, 20(7):981\u2013984. 10.1097\/01.aids.0000222069.14878.44","journal-title":"AIDS"},{"issue":"Suppl 3","key":"4867_CR25","first-page":"A25","volume":"13","author":"G Picchio","year":"2008","unstructured":"Picchio G, Vingerhoets J, Parkin N, Azijn H, de Bethune MP: Nucleoside-associated mutations cause hypersusceptibility to etravirine. Antivir Ther 2008, 13(Suppl 3):A25.","journal-title":"Antivir Ther"},{"issue":"6","key":"4867_CR26","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1128\/AAC.38.6.1404","volume":"38","author":"VW Byrnes","year":"1994","unstructured":"Byrnes VW, Emini EA, Schleif WA, Condra JH, Schneider CL, Long WJ, Wolfgang JA, Graham DJ, Gotlib L, Schlabach AJ: Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. Antimicrob Agents Chemother 1994, 38(6):1404\u20131407.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"4867_CR27","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1128\/AAC.36.12.2664","volume":"36","author":"BA Larder","year":"1992","unstructured":"Larder BA: 3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 1992, 36(12):2664\u20132669.","journal-title":"Antimicrob Agents Chemother"},{"issue":"20","key":"4867_CR28","doi-asserted-by":"publisher","first-page":"12773","DOI":"10.1128\/JVI.79.20.12773-12782.2005","volume":"79","author":"J Vingerhoets","year":"2005","unstructured":"Vingerhoets J, Azijn H, Fransen E, De Baere I, Smeulders L, Jochmans D, Andries K, Pauwels R, de B\u00e9thune MP: TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments. J Virol 2005, 79(20):12773\u201312782. 10.1128\/JVI.79.20.12773-12782.2005","journal-title":"J Virol"},{"key":"4867_CR29","volume-title":"SUGI 31 Proceedings, San Francisco, CA","author":"RA Cohen","year":"2006","unstructured":"Cohen RA: Introducing the GLMSELECT PROCEDURE for Model Selection. SUGI 31 Proceedings, San Francisco, CA 2006. Paper 207\u201331 Paper 207-31"},{"key":"4867_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1080\/01621459.1992.10475275","volume":"87","author":"P Zhang","year":"1992","unstructured":"Zhang P: On the Distributional Properties of Model Selection Criteria. J Am Stat Ass 1992, 87: 732\u2013737. 10.2307\/2290211","journal-title":"J Am Stat Ass"},{"issue":"2","key":"4867_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/jac\/42.2.269","volume":"42","author":"K Hertogs","year":"1998","unstructured":"Hertogs K, de B\u00e9thune MP, Miller V, Ivens T, Schel P, Van Cauwenberge A, Van Den Eynde C, Van Gerwen V, Azijn H, Van Houtte M, Peeters F, Staszewski S, Conant M, Bloor S, Kemp S, Larder B, Pauwels R: A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother 1998, 42(2):269\u2013276. 10.1093\/jac\/42.2.269","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4867_CR32","first-page":"179","volume":"8","author":"CF Perno","year":"2006","unstructured":"Perno CF, Svicher V, Ceccherini-Silberstein F: Novel drug resistance mutations in HIV: recognition and clinical relevance. AIDS Rev 2006, 8(4):179\u2013190.","journal-title":"AIDS Rev"},{"issue":"2","key":"4867_CR33","first-page":"67","volume":"10","author":"RW Shafer","year":"2008","unstructured":"Shafer RW, Schapiro JM: HIV-1 drug resistance mutations: an updated framework for the second decade of HAART. AIDS Rev 2008, 10(2):67\u201384.","journal-title":"AIDS Rev"},{"key":"4867_CR34","volume-title":"15th Conference on Retroviruses and Opportunistic Infections, Boston, MA","author":"B Winters","year":"2008","unstructured":"Winters B, Villacian J, Van Craenenbroeck E, Bacheler L: Development of vircoTYPE HIV-1 resistance analysis, including clinical cutoffs for TMC125, a new NNRTI. 15th Conference on Retroviruses and Opportunistic Infections, Boston, MA 2008. Abstract 873 Abstract 873"},{"issue":"1-2","key":"4867_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jviromet.2009.07.023","volume":"162","author":"B Winters","year":"2009","unstructured":"Winters B, Van Craenenbroeck E, Van der Borght K, Lecocq P, Villacian J, Bacheler L: Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixtures. J Virol Methods 2009, 162(1\u20132):101\u2013108. 10.1016\/j.jviromet.2009.07.023","journal-title":"J Virol Methods"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-12-386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2105-12-386\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-12-386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T18:37:57Z","timestamp":1686422277000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-12-386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["4867"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-12-386","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,3]]},"article-number":"386"}}